# LIVDELZI
> **NDA217899** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2024-08-14
## Drug
- **FDA Application Number:** NDA217899
- **Application type:** New Drug Application
- **Brand name:** LIVDELZI
- **Generic name:** SELADELPAR LYSINE
- **Active ingredients:** SELADELPAR LYSINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc
- **First approval:** 2024-08-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217899)
---
*MORVS · CC0 1.0*